Dr. Noon CVD

Regulation Info

Dr. Noon CVD_Korea MFDS : [Product Name] DrNoon for CVD / [Product License No.] 제허 22-513호 / [Date of Initial Approval] 1 August 2022 / [Validity Period]1 August 2022 – 31 July 2027 [Issuer ] The Ministry of Food and Drug Safety
Dr. Noon CVD_CE : EC Certificate issued under the European Medical Device Regulation (EU MDD) / [EC Certificate No.] KR21/81826550 / [First Issue Date] 11 May 2021 / [Expiry Date] 31 December 2028 / [Issuer] SGS Belgium NV
Dr. Noon CVD_FDA : Under the DeNovo Pathway

AI-powered Solution for
Cardiovascular Disease Risk Assessment

Dr. Noon CVD is a retina-based AI solution that predicts the future risk of cardiovascular disease.
It is the world’s first AI-powered solution utilizing retinal imaging to assess cardiovascular risk.

In Korea, it is commercialized with regulatory approval and reimbursement, making it widely accessible in clinical practice. Globally, it is commercialized in Dubai, UK, and Italy with regulatory approvals in 8 regions. Adopted in many hospitals and clinics, it provides accurate, non-invasive, and cost-effective methods.

How Dr. Noon CVD Uses AI
for Cardiovascular Health

Cardiovascular diseases develop silently over time and can lead to fatal conditions such as heart
attacks and strokes. Early detection is crucial to prevent severe complications before they occur.
Watch the video to learn how Dr. Noon CVD leverages AI and retinal imaging
for cardiovascular risk assessment.

Patient Journey

Follow the step-by-step journey of a patient visiting the hospital
and see how they meet Dr. Noon CVD.

STEP 1

Patient Identification
If a patient is suspected of being at risk for cardiovascular disease—such as those with diabetes, hypertension, hyperlipidemia, or obesity
—the Dr. Noon CVD is recommended.
STEP 2

Clinical Consultation
A medical professional conducts a consultation, reviewing the patient’s medical history and current health status.
STEP 3

Eye Scan
Take one picture of each eye to capture the retina.
STEP 4

Image Upload
The retinal images are uploaded to the healthcare institution’s server or cloud platform.
STEP 5

AI Analysis
Artificial intelligence automatically
analyzes the images to assess the patient’s risk of cardiovascular disease.
STEP 6

Result Review
The risk of cardiovascular disease is determined through an automatically generated report.

Comparison with
Traditional Methods

A comparison with traditional methods highlights Dr. Noon CVD's superior performance
over conventional tests in assessing cardiovascular risk.

Dr. Noon CVD vs Traditional Methods

Heart CT
Carotid Ultrasound
Pulse Wave Velocity

Type
Ease of Use
Accessibility
Footprint & Equipment
Radiation Exposure
Cost
Turnaround Time
Operator
Dependency
Risk
Prediction Accuracy

Dr. Noon CVD

Type
Retina-based coronary
calcium score prediction
Ease of Use
Easy (Simple retinal photo, <3 min)
Accessibility
High (Usable in primary care)
Footprint & Equipment
Small (Requires only fundus camera)
Radiation Exposure
None
Cost
Low (Affordable)
Turnaround Time
Fast (Instant AI result, <3 min)
Operator
Dependency
Low (Minimal training needed)
Risk
Prediction Accuracy
High (Comparable to CACS)

Heart CT

Type
Imaging with radiation
Ease of Use
Difficult (Needs specialized CT machine)
Accessibility
Low (Tertiary care only)
Footprint & Equipment
Large (Expensive CT scanner required)
Radiation Exposure
Yes (Involves radiation)
Cost
High (Expensive)
Turnaround Time
Slow (Multi-step processing)
Operator
Dependency
High (Requires technician, radiologist)
Risk
Prediction Accuracy
High (Current gold standard)

Carotid Ultrasound

Type
Ultrasound-based IMT
Ease of Use
Difficult (Needs trained sonographer)
Accessibility
Low (Tertiary care only)
Footprint & Equipment
Large (Handheld device + trained operator)
Radiation Exposure
None
Cost
Moderate (Varies)
Turnaround Time
Slow (≥10 min + post-analysis)
Operator
Dependency
High (Sonographer or physician required)
Risk
Prediction Accuracy
Moderate (Lower than CACS)

Pulse Wave Velocity

Type
Vascular stiffness measure
Ease of Use
Difficult (Needs specialized equipment)
Accessibility
Low (Tertiary care only)
Footprint & Equipment
Large (Niche equipment, not widely used)
Radiation Exposure
None
Cost
Moderate (Varies)
Turnaround Time
Variable (Depends on setup)
Operator
Dependency
Medium (Operator influences result)
Risk
Prediction Accuracy
Moderate (Lower than CACS)

Key Benefits

High Accuracy
Predicts cardiovascular disease risk with accuracy comparable to
heart CT.
Safe & Non-Invasive
Requires no needle injection or radiation exposure, making it comfortable for patients.
Cost-Effective
Compared to conventional cardiovascular screenings, the test is available at a more affordable cost.
Fast Test Results
Results are delivered promptly, allowing patients to receive their reports without delay.
High Accessibility
Designed for wide use across clinics, hospitals, and health screening centers, enabling broader access to risk assessment.

Our Customers

Dr. Noon CVD is utilized by leading hospitals, clinics, and check-up centers in Korea and worldwide,
offering early cardiovascular risk assessments to patients.